FDA says this weight loss drug shortage is over

Weight-loss drugs didn't curb health costs within two years
Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims shared with Reuters.
Competition will make weight-loss drugs better, cheaper and bigger
A mong the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking remedies for erectile dysfunction and hair loss. Since May it has offered its own version of Wegovy,
FDA says this weight loss drug shortage is over, but patients worry about cost and availability
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
CBO Estimates Medicare Coverage of Weight-Loss Drugs
In a much-anticipated release, the Congressional Budget Office (CBO) published projections estimating it would cost Medicare an additional $35 billion from 2026-2034 to cover anti-obesity medications (AOMs).
Use of Weight Loss Drug Widespread, and Costly
As obesity rates in the United States soar, insurance companies, including Medicaid and Medicare, are facing financial headwinds to pay for prescription drugs for weight loss. Semaglutide, the generic name for Mounjaro,
Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
Latest weight-loss drug faces shortages
The United States Food and Drug Administration (FDA) says that high demand has left the latest weight-loss drug, Zepbound, in short supply.
Eli Lilly Sues Over Knock-Off Weight-Loss Drugs
Eli Lilly has filed three new separate lawsuits accusing vendors and a medical spa of selling knock-off versions of their drug, Zepbound.
US Medicaid programs say cost a key factor for weight-loss drug coverage, survey finds
Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...
valuepenguin10d
Costs and Insurance Coverage for Ozempic, Wegovy & Weight Loss Drugs
Weight loss drugs like Ozempic and Wegovy cost an average of $1,116 per month or $13,397 per year if you pay full price. Find Cheap Health Insurance Quotes in Your Area Weight loss drugs ...
CNBC on MSN9d
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Medicare coverage of the drugs would up federal spending by $35 billion from 2026 to 2034. Meanwhile, CNBC tests Abbott’s ...
Medindia2d
Bariatric Surgery and Weight Loss Drugs: A Cost-Effective Duo for Weight Control
A study presented at the American College of Surgeons (ACS) Clinical Congress 2024 in San Francisco suggests that newer weight loss medications are only cost-effective in the long run when ...
The Financial Express23h
Data shows weight-loss drugs didn’t curb health costs within two years: Report
Prime Therapeutics reviewed pharmacy and medical claims data for 3,046 people with commercial health plans that cover GLP-1 ...
KSL1d
Medicaid programs say cost a key factor for weight-loss drug coverage, survey finds
Most U.S. states do not currently cover highly sought-after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...